Shedir Pharma Srl Unipersonale Stock

Shedir Pharma Srl Unipersonale Equity 2025

Shedir Pharma Srl Unipersonale Equity

35.96 M EUR

Ticker

SHE.MI

ISIN

IT0005379620

In 2025, Shedir Pharma Srl Unipersonale's equity was 35.96 M EUR, a 9.73% increase from the 32.77 M EUR equity in the previous year.

Shedir Pharma Srl Unipersonale Aktienanalyse

What does Shedir Pharma Srl Unipersonale do?

Shedir Pharma Srl Unipersonale ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Shedir Pharma Srl Unipersonale's Equity

Shedir Pharma Srl Unipersonale's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Shedir Pharma Srl Unipersonale's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Shedir Pharma Srl Unipersonale's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Shedir Pharma Srl Unipersonale's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Shedir Pharma Srl Unipersonale’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Shedir Pharma Srl Unipersonale stock

What is the equity of Shedir Pharma Srl Unipersonale this year?

Shedir Pharma Srl Unipersonale has equity of 35.96 M EUR this year.

What was the equity of Shedir Pharma Srl Unipersonale compared to the previous year?

The equity of Shedir Pharma Srl Unipersonale has increased/decreased by 9.73% increased compared to the previous year.

What impact does a high equity have on investors of Shedir Pharma Srl Unipersonale?

A high equity is advantageous for investors of Shedir Pharma Srl Unipersonale as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Shedir Pharma Srl Unipersonale?

A low equity can be a risk for investors of Shedir Pharma Srl Unipersonale, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Shedir Pharma Srl Unipersonale affect the company?

An increase in equity of Shedir Pharma Srl Unipersonale can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Shedir Pharma Srl Unipersonale affect the company?

A reduction in equity of Shedir Pharma Srl Unipersonale can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Shedir Pharma Srl Unipersonale?

Some factors that can affect the equity of Shedir Pharma Srl Unipersonale include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Shedir Pharma Srl Unipersonale so important for investors?

The equity of Shedir Pharma Srl Unipersonale is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Shedir Pharma Srl Unipersonale take to change the equity?

To change equity, Shedir Pharma Srl Unipersonale can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Shedir Pharma Srl Unipersonale pay?

Over the past 12 months, Shedir Pharma Srl Unipersonale paid a dividend of 0.34 EUR . This corresponds to a dividend yield of about 7.07 %. For the coming 12 months, Shedir Pharma Srl Unipersonale is expected to pay a dividend of 0.38 EUR.

What is the dividend yield of Shedir Pharma Srl Unipersonale?

The current dividend yield of Shedir Pharma Srl Unipersonale is 7.07 %.

When does Shedir Pharma Srl Unipersonale pay dividends?

Shedir Pharma Srl Unipersonale pays a quarterly dividend. This is distributed in the months of June, June, June, June.

How secure is the dividend of Shedir Pharma Srl Unipersonale?

Shedir Pharma Srl Unipersonale paid dividends every year for the past 7 years.

What is the dividend of Shedir Pharma Srl Unipersonale?

For the upcoming 12 months, dividends amounting to 0.38 EUR are expected. This corresponds to a dividend yield of 7.81 %.

In which sector is Shedir Pharma Srl Unipersonale located?

Shedir Pharma Srl Unipersonale is assigned to the 'Health' sector.

Wann musste ich die Aktien von Shedir Pharma Srl Unipersonale kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Shedir Pharma Srl Unipersonale from 5/10/2023 amounting to 0.175 EUR, you needed to have the stock in your portfolio before the ex-date on 5/8/2023.

When did Shedir Pharma Srl Unipersonale pay the last dividend?

The last dividend was paid out on 5/10/2023.

What was the dividend of Shedir Pharma Srl Unipersonale in the year 2024?

In the year 2024, Shedir Pharma Srl Unipersonale distributed 0.345 EUR as dividends.

In which currency does Shedir Pharma Srl Unipersonale pay out the dividend?

The dividends of Shedir Pharma Srl Unipersonale are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Shedir Pharma Srl Unipersonale

Our stock analysis for Shedir Pharma Srl Unipersonale Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Shedir Pharma Srl Unipersonale Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.